TipRanks
Nutrien Ltd (MX:NTRN)
:NTRN
Mexico Market
EarningsQ2 2026 Earnings Report

Nutrien (NTRN) Q2 2026 Earnings Report

0 Followers

MX:NTRN Q2 2026 EPS Results

Actual EPS$46.49
Consensus EPS$48.40
Beat/MissMissed by -$1.91
One Year Ago EPS$46.33

MX:NTRN Q2 2026 Revenue Results

Actual Revenue$190.13B
Expected Revenue$188.44B
Beat/MissBeat by +$1.70B
YoY Revenue Growth+3.56%

Earnings Announcement Details

QuarterQ2 2026
Date08/05/2026
TimeAfter Close
Conference CallWednesday, August 5, 2026
MX:NTRN Upcoming Earnings
Nutrien's next earnings date is estimated for November 4, 2026, based on past reporting schedules.

Q2 2026 Earnings Call Audio

MX:NTRN Q2 2026 Earnings Call
0:00 / 0:00

Q2 2026 Earnings Slide Deck

Q2 2026 Earnings Call Summary

Q2 2026
Earnings Call Date:Aug 05, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call presents a generally positive tone: the company achieved record potash volumes, modest EBITDA growth (+6% H1), stronger cash flow (+12% H1), successful operational execution (automation, major turnaround), and increased shareholder returns (capex reduction and stepped-up buybacks). Offsetting items include notable weakness in phosphate margins from soaring sulfur costs, lower retail fertilizer volumes (phosphate down ~10%, nitrogen down ~7% in downstream), higher retail SG&A (fuel/fleet), seed profit weakness, and continuing geopolitical and weather-related market uncertainties. On balance, the strengths in operations, cash generation and capital allocation outweigh the challenges described.
Company Guidance
Nutrien maintained a fairly constructive 2026 guidance framework with many specifics: global potash shipments are forecast at 74–77 million tonnes and Nutrien raised its own potash sales guidance to 14.2–14.8 Mt (Q2 potash adj. EBITDA $658M; controllable cash cost targeted below $60/tonne; Canpotex fully committed for Q3; 53% of ore tonnes mined with automation in H1; current capacity ~15 Mt with options to 18 Mt at ~$200–$300/t incremental capital and larger step‑ups at ~$700–$800/t). Nitrogen sales volume guidance was maintained at 9.2–9.7 Mt (Q2 nitrogen adj. EBITDA $635M; ~35% of segment volumes sold before the Middle East conflict; Carseland turnaround completed; turnarounds planned at Lima and Redwater in Q3). Phosphate volumes guidance was unchanged but margins are pressured by elevated sulfur costs. Downstream retail adj. EBITDA guidance was reaffirmed at $1.75–$1.95B (H1 retail adj. EBITDA $1.24B, +4%), with proprietary products gross margin up ~10% in H1 and expected to grow high single digits for the full year. Company results underpinning guidance included Q2 adj. EBITDA $2.4B, H1 adj. EBITDA $3.5B (+6% y/y), cash from operations +12% H1; CapEx guidance trimmed by $50M to $1.95–$2.05B; divestiture proceeds ~ $90M since June and ~ $1B since Q4 2024; and share repurchases up 26% in H1 and ramped to ~ $75M/month in Q3.
Strong Financial Performance
Second quarter adjusted EBITDA of $2.4 billion and first half adjusted EBITDA of $3.5 billion (up 6% year-over-year); cash provided by operating activities increased 12% in the first half.
Record Potash Volumes and Improved Cost Position
Delivered record potash sales volumes in H1 2026; raised the bottom end of 2026 potash sales volumes guidance to 14.2–14.8 million tonnes; controllable cash cost of product manufactured for potash was flat year-over-year with a full‑year target below $60/tonne.
Automation and Operational Efficiency
Mined 53% of ore tonnes using automation in H1 (exceeding the top end of 2024 Investor Day target), enabling higher productivity, optimized capital expenditure needs and improved safety outcomes.
Nitrogen and Potash Segment Strength
Q2 potash adjusted EBITDA of $658 million and Q2 nitrogen adjusted EBITDA of $635 million; North American nitrogen assets described as low‑cost and well positioned amid market volatility.
Downstream / Retail Execution and Proprietary Products Growth
Downstream retail adjusted EBITDA of $1.24 billion in H1 (up 4% year-over-year); proprietary crop nutrients gross margin increased (company cited a 10% increase in H1 proprietary crop nutrients gross margin) and sales volumes for certain nutritional products rose nearly tenfold versus prior year.
Capital Allocation and Shareholder Returns
Reduced 2026 capital expenditures guidance by $50 million to $1.95–$2.05 billion; increased share repurchases by 26% in H1 year-over-year and accelerated repurchase pace in Q3 to approximately $75 million per month.
Portfolio Optimization and Balance Sheet Actions
Completed agreements to sell non-core assets for gross proceeds of ≈$90 million since June 2026 and ~ $1 billion in gross proceeds since Q4 2024; reviewing strategic alternatives for phosphate, Trinidad nitrogen and parts of Brazilian retail.
Operational Milestones and Turnaround Execution
Completed the largest-ever Carseland turnaround ahead of schedule, under budget and safely (0 lost-time injuries); debottlenecking project increased annual production capacity.

MX:NTRN Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Nov 04, 2026
2026 (Q3)
16.77 / -
17.415―
2026 (Q2)
48.40 / 46.49
46.3270.36% (+0.17)
2026 (Q1)
9.34 / 8.83
1.944354.25% (+6.88)
2025 (Q4)
15.80 / 14.43
5.589158.18% (+8.84)
2025 (Q3)
17.07 / 17.42
6.872153.42% (+10.54)
2025 (Q2)
41.83 / 46.33
40.86513.37% (+5.46)
2025 (Q1)
5.42 / 1.94
8.003-75.71% (-6.06)
2024 (Q4)
6.00 / 5.59
6.351-12.00% (-0.76)
2024 (Q3)
7.94 / 6.87
6.13512.01% (+0.74)
2024 (Q2)
38.06 / 40.86
42.961-4.88% (-2.10)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed